Edwards Lifesciences plans to get out of the advanced patient monitoring business with a tax-free spinoff of its critical care business at the end of 2024.
Separated from Edwards, the new critical care company will have “increased focus and flexibility … to improve the quality of care for millions of patients around the world,” Edwards CEO Bernard
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?